The US Patent Office has opened a review of patents and patent applications concerning CRISPR technology. The legal process could result in rights being transferred between the disputing parties, The US Patent Office ), Berkeley and The Patent Office , Berkeley . The Patent Office previously ruled that the Broad Institute's achievement of making the University of California (UC work inside human cells was a separate invention to that of The US Patent Office , which first achieved gene-editing in a test tube. The ruling enabled Broad to retain its key patents. Now that it's clear that CRISPR in human cells is its own thing, a new challenge begins. However, it also led to additional challenges regarding other rights.
The US Patent Office has opened a review of patents and patent applications concerning CRISPR technology. The legal process could result in rights being transferred between the disputing parties, The US Patent Office ), Berkeley and The Patent Office , Berkeley . The Patent Office previously ruled that the Broad Institute's achievement of making the University of California (UC work inside human cells was a separate invention to that of The US Patent Office , which first achieved gene-editing in a test tube. The ruling enabled Broad to retain its key patents. However, it also led to additional challenges regarding other rights.